- Home
- PHIO vs NURO Comparison
PHIO vs NURO Comparison
Compare PHIO & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- NURO
- Stock Information
- Founded
- PHIO 2011
- NURO 1996
- Country
- PHIO United States
- NURO United States
- Employees
- PHIO N/A
- NURO N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- NURO Medical/Dental Instruments
- Sector
- PHIO Health Care
- NURO Health Care
- Exchange
- PHIO Nasdaq
- NURO Nasdaq
- Market Cap
- PHIO 8.0M
- NURO 8.2M
- IPO Year
- PHIO N/A
- NURO N/A
- Fundamental
- Price
- PHIO $1.67
- NURO $4.39
- Analyst Decision
- PHIO Strong Buy
- NURO
- Analyst Count
- PHIO 1
- NURO 0
- Target Price
- PHIO $36.00
- NURO N/A
- AVG Volume (30 Days)
- PHIO 981.0K
- NURO 15.9K
- Earning Date
- PHIO 04-01-2025
- NURO 03-04-2025
- Dividend Yield
- PHIO N/A
- NURO N/A
- EPS Growth
- PHIO N/A
- NURO N/A
- EPS
- PHIO N/A
- NURO N/A
- Revenue
- PHIO N/A
- NURO $3,767,764.00
- Revenue This Year
- PHIO N/A
- NURO N/A
- Revenue Next Year
- PHIO N/A
- NURO N/A
- P/E Ratio
- PHIO N/A
- NURO N/A
- Revenue Growth
- PHIO N/A
- NURO N/A
- 52 Week Low
- PHIO $1.53
- NURO $2.66
- 52 Week High
- PHIO $10.35
- NURO $4.73
- Technical
- Relative Strength Index (RSI)
- PHIO 42.10
- NURO 63.96
- Support Level
- PHIO $1.64
- NURO $4.35
- Resistance Level
- PHIO $1.88
- NURO $4.45
- Average True Range (ATR)
- PHIO 0.13
- NURO 0.06
- MACD
- PHIO -0.02
- NURO -0.00
- Stochastic Oscillator
- PHIO 5.61
- NURO 60.39
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.